Brief: Marksans Pharma - UK MHRA Granted Market Authorisation To Unit For Loperamide
09/12/2021 14:17
Dec 9 (Reuters) - Marksans Pharma Ltd MARK.NS :
* MARKSANS PHARMA - UK MHRA GRANTED MARKET AUTHORISATION TO
UNIT,
RELONCHEM FOR LOPERAMIDE 2MG HARD CAPSULES
* MARKSANS PHARMA - WILL MANUFACTURE PRODUCTS AT FACILITY
LOCATED
AT GOA
Source text for Eikon: ID:nBSE8zQknl
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg